Jan 22 (Reuters) - Tiziana Life Sciences Ltd TLSA.O:
TIZIANA LIFE SCIENCES ANNOUNCES DISCOVERY OF NEW IMMUNE BIOMARKERS IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH NASAL FORALUMAB
TIZIANA LIFE SCIENCES LTD - GENE EXPRESSION CHANGES DETECTED THREE MONTHS AFTER FORALUMAB DOSING
Source text: ID:nGNX6FqjN3
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.